Sustainable treatment of glaucoma patients with cardiovascular diseases
As life expectancy increases, the incidence of glaucoma is expected to rise worldwide. The review presents data on the comorbidity and polypharmacy of old and senile patients with glaucoma. Such patients also often have polypathia: on average, they have 6.3±0.6 concomitant somatic diseases. Appro...
Saved in:
| Main Authors: | L. V. Yakubova, S. M. Kosakyan, L. V. Vasilenkova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Real Time Ltd
2020-09-01
|
| Series: | Российский офтальмологический журнал |
| Subjects: | |
| Online Access: | https://roj.igb.ru/jour/article/view/495 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beta-blockers in modern glaucoma therapy. Review
by: O. A. Kiseleva, et al.
Published: (2014-07-01) -
Optimization of Medicinal Treatment of Patients with Glaucoma in Combination with Concurrent System Pathology. Part 1: Cardiovascular Pathology
by: A. N. Zhuravleva, et al.
Published: (2020-09-01) -
POLYMORBIDITY: SPECIFICS OF CO-DEVELOPMENT AND CONCOMITANCE OF SEVERAL DISEASES IN ONE PATIENT
by: R. G. Oganov, et al.
Published: (2016-08-01) -
Drug Utilization Study In Primary Glaucoma Patients Attending the Ophthalmology Outpatient Department of a Tertiary Care Hospital in Western Uttar Pradesh
by: Nazia Parween, et al.
Published: (2017-01-01) -
Polypharmacy and Polytherapy: Current Perspectives on Risk–Benefit Balance and Strategies for Optimization of Multidrug Treatment in Patients
by: Agata Sozańska, et al.
Published: (2025-06-01)